全文获取类型
收费全文 | 16733篇 |
免费 | 1329篇 |
国内免费 | 525篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 472篇 |
妇产科学 | 236篇 |
基础医学 | 1863篇 |
口腔科学 | 339篇 |
临床医学 | 1762篇 |
内科学 | 3258篇 |
皮肤病学 | 299篇 |
神经病学 | 1015篇 |
特种医学 | 568篇 |
外国民族医学 | 8篇 |
外科学 | 1784篇 |
综合类 | 1716篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 1317篇 |
眼科学 | 506篇 |
药学 | 1415篇 |
19篇 | |
中国医学 | 615篇 |
肿瘤学 | 1180篇 |
出版年
2024年 | 44篇 |
2023年 | 196篇 |
2022年 | 418篇 |
2021年 | 661篇 |
2020年 | 468篇 |
2019年 | 472篇 |
2018年 | 640篇 |
2017年 | 496篇 |
2016年 | 472篇 |
2015年 | 641篇 |
2014年 | 770篇 |
2013年 | 832篇 |
2012年 | 1165篇 |
2011年 | 1287篇 |
2010年 | 776篇 |
2009年 | 586篇 |
2008年 | 878篇 |
2007年 | 886篇 |
2006年 | 787篇 |
2005年 | 808篇 |
2004年 | 702篇 |
2003年 | 689篇 |
2002年 | 669篇 |
2001年 | 521篇 |
2000年 | 549篇 |
1999年 | 465篇 |
1998年 | 149篇 |
1997年 | 137篇 |
1996年 | 141篇 |
1995年 | 117篇 |
1994年 | 63篇 |
1993年 | 66篇 |
1992年 | 152篇 |
1991年 | 126篇 |
1990年 | 107篇 |
1989年 | 114篇 |
1988年 | 93篇 |
1987年 | 80篇 |
1986年 | 72篇 |
1985年 | 50篇 |
1984年 | 39篇 |
1983年 | 23篇 |
1982年 | 13篇 |
1981年 | 10篇 |
1980年 | 11篇 |
1979年 | 14篇 |
1977年 | 12篇 |
1973年 | 9篇 |
1970年 | 9篇 |
1965年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献4.
5.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
6.
7.
8.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献
9.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
10.